CBR Makes Newborn Stem Cell Preservation Easy

Woman checking echos on couch

CBR is a leader in the newborn stem cell preservation industry. The company has partnered with several major research facilities to explore the benefits of the use of stem cells in the field of regenerative medicine, especially in the area of pediatrics.

CBR will be at the New York Baby Show on May 20 and 21, at Pier 94.

The nation’s largest show for expectant and new families, the New York Baby Show is a wonderful family-friendly mega-event featuring everything to do with maternity, baby, and toddler. From top products to trusted parenting experts, the New York Baby Show welcomes thousands of expectant and new parents from New York City, the Tri-State area, and beyond!

Tickets to the New York Baby Show are $30 per family, and $20 per individual.


To learn more about CBR, we spoke with Jennifer Eddy, the company’s product marketing manager.

For someone unfamiliar with CBR, how would you describe the company’s mission and core offerings?

Every parent wants to make the world a better place for their children. CBR’s mission is to help create that better place. We believe in the awesomeness of newborn stem cells and their potential for the future. At a time when expecting parents are making a million decisions about their baby, CBR wants to make one easy: the choice to preserve your baby’s newborn stem cells.

Tell us about the company’s background. When did it start and how has it evolved since then?

Founded 25 years ago, CBR has established itself as the leader in the newborn stem cell preservation industry. Since then, more than 500,000 families have entrusted their child’s newborn stem cells to CBR’s care. In that time, CBR has:

  • Partnered with 5 reputable research institutions on FDA-regulated clinical trials in regenerative medicine for CBR client participation. CBR is working to improve the lives of children living with cerebral palsy, autism, acquired hearing loss, and pediatric stroke.
  • Released more than 350 cord blood samples for use by families that have stored with CBR.
  • Invested $3 million in clinical trials, a medical advisory board, and strategic partnerships to advance the field.
  • Provided free preservation services to 6,000 families with a qualifying medical need as part of our Newborn Possibilities Program.
  • Our 80,000 sq. ft. state-of-the-art processing and storage laboratory in Tucson, Arizona was built to help ensure the long-term safety of our families’ newborn stem cells.

What are the most popular and newest services from CBR?

A baby’s umbilical cord is made up of tissue and contains blood, both of which are rich sources of powerful stem cells. In addition to the current use of cord blood in transplant medicine, cord blood and cord tissue stem cells may offer benefits in potential future uses, such as regenerative medicine. We believe that every expecting parent should know that preserving their newborn’s stem cells may open doors for stem cell treatments in the future.

To learn more, check out the Cord Blood 101 video.

What sets CBR apart in the marketplace?

CBR has preserved newborn stem cells for more than half a million children—more than any other cord blood company. CBR is dedicated to advancing the clinical applications of newborn stem cells. That’s why we partner with researchers on FDA-regulated clinical trials to advance newborn stem cell research and connect families to these trials if they qualify. Our commitment to parents and their babies is to provide the best service and quality in collection, processing, and storing of the stem cells, so that families are confident entrusting their precious cells to our care.

What can parents expect from CBR at the New York Baby Show?

We’re ready to help you with the info you need! We can chat with you about the basics of what newborn stem cells are, what they can do, and how the collection process works. Have questions? Ready to sign up and get your kit? We can help with that, too!

To learn more about the CBR, check out cordblood.com.

Disclaimer from CBR:

Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Should such use become available, cord tissue will require additional processing prior to use. CBR is currently evaluating the potential to isolate and prepare multiple cell types from cryopreserved cord tissue for potential future use.

Cbr Systems, Inc.’s activities for New York State residents are limited to collection of umbilical cord tissue and long-term storage of umbilical cord–derived stem cells. Cbr Systems, Inc.’s possession of a New York State license for such collection and long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.